Inventor · disambiguated record
Samit Hirawat
Also filed as: HIRAWAT SAMIT
19 granted patents·12 pending applications·127 citations·filing 2006–2020
94Inventor score
Top patents by PatentIndex Score
31 records- 0193US8716321B2Methods for dosing an orally active 1,2,4-oxadiazoleHIRAWAT SAMIT·Filed 2006·Granted May 6, 2014·29 cites·31 claims
- 0293US8076352B2Administration of carboline derivatives useful in the treatment of cancer and other diseasesCAO LIANGXIAN·Filed 2007·Granted Dec 13, 2011·30 cites·18 claims
- 0391US9522137B2Methods for dosing an orally active 1,2,4-Oxadiazole for nonsense mutation suppression therapyPTC THERAPEUTICS INC·Filed 2015·Granted Dec 20, 2016·8 cites·10 claims
- 0490US9877952B2Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapyPTC THERAPEUTICS INC·Filed 2017·Granted Jan 30, 2018·6 cites·9 claims
- 0590US9737513B2Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapyPTC THERAPEUTICS INC·Filed 2016·Granted Aug 22, 2017·6 cites·9 claims
- 0689US10034863B2Compositions for an orally active 1,2,4-oxadiazole for the treatment of diseasePTC THERAPEUTICS INC·Filed 2016·Granted Jul 31, 2018·5 cites·8 claims
- 0789US9474743B2Compositions for an orally active 1,2,4-oxadiazole for the treatment of diseasePTC THERAPEUTICS INC·Filed 2014·Granted Oct 25, 2016·8 cites·15 claims
- 0888US10172836B2Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation supression therapyPTC THERAPEUTICS INC·Filed 2018·Granted Jan 8, 2019·4 cites·9 claims
- 0988US9226919B2Methods for dosing an orally active 1,2,4-oxadiazoleHIRAWAT SAMIT·Filed 2007·Granted Jan 5, 2016·10 cites·14 claims
- 1086US9289398B2Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewithALMSTEAD NEIL·Filed 2007·Granted Mar 22, 2016·9 cites·6 claims
- 1186US8703726B2Methods for treating prostate conditionsCAO LIANGXIAN·Filed 2010·Granted Apr 22, 2014·6 cites·15 claims
- 1285US8697662B2Methods for treating Kaposi sarcomaCAO LIANGXIAN·Filed 2010·Granted Apr 15, 2014·5 cites·18 claims
- 1379US10285980B2Compositions for an orally active 1,2,4-oxadiazole for the treatment of diseasePTC THERAPEUTICS INC·Filed 2018·Granted May 14, 2019·1 cites·13 claims
- 1476US10675272B2Compositions for an orally active 1,2,4-oxadiazole for the treatment of diseasePTC THERAPEUTICS INC·Filed 2019·Granted Jun 9, 2020·0 cites·13 claims
- 1574US2021038572A1Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapyPTC THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1672US11497736B2Compositions for an orally active 1,2,4-oxadiazole for the treatment of diseasePTC THERAPEUTICS INC·Filed 2020·Granted Nov 15, 2022·0 cites·13 claims
- 1769US10849885B2Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapyPTC THERAPEUTICS INC·Filed 2018·Granted Dec 1, 2020·0 cites·10 claims
- 1860US10213432B2Dosage regimen for a PI-3 kinase inhibitorNOVARTIS AG·Filed 2013·Granted Feb 26, 2019·0 cites·2 claims
- 1957US2019134052A1Dosage regimen for a pi-3 kinase inhibitorNOVARTIS AG·Filed 2018·Application pending·0 cites
- 2050US10085996B2Pharmaceutical combinationsNOVARTIS AG·Filed 2017·Granted Oct 2, 2018·0 cites·7 claims
- 2148US2010158858A1Administration of carboline derivatives useful in the treatment of cancer and other diseasesCAO LIANGXIAN·Filed 2008·Application pending·0 cites
- 2247US9913846B2Combination of a PI3 kinase inhibitor with pacitaxel for use in the treatment or prevention of a cancer of the head and neckNOVARTIS AG·Filed 2017·Granted Mar 13, 2018·0 cites·3 claims
- 2346US2012129841A1Carboline derivatives useful in the treatment of cancer and other diseasesCAO LIANGXIAN·Filed 2011·Application pending·0 cites
- 2445US2016082012A1Combination of a PI3 Kinase Inhibitor with Pacitaxel for Use in the Treatment or Prevention of a Cancer of the Head and NeckHIRAWAT SAMIT·Filed 2014·Application pending·0 cites
- 2544US2016199357A1Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associated therewithPTC THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2642US2012202801A1Methods for treating breast cancerCAO LIANGXIAN·Filed 2010·Application pending·0 cites
- 2742US2012157402A1Methods for treating brain tumorsCAO LIANGXIAN·Filed 2010·Application pending·0 cites
- 2839US2016129003A1Pharmaceutical CombinationsHIRAWAT SAMIT·Filed 2014·Application pending·0 cites
- 2939US2015157645A1Combination of a 17-alpha-hydroxylase (c17,20-lyase) inhibitor and a specific pi-3k inhibitor for treating a tumor diseaseHIRAWAT SAMIT·Filed 2013·Application pending·0 cites
- 3035US2016331755A1Pharmaceutical CombinationsHIRAWAT SAMIT·Filed 2015·Application pending·0 cites
- 3130US2018256557A1Pharmaceutical combination comprising (a) the alpha-isoform specific pi3k inhibitor alpelisib (byl719) and (b) an akt inhibitor, preferably mk-2206, afuresertib or uprosertib, and the use thereof in the treatment/prevention of cancerCAPONIGRO GIORDANO·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Samit Hirawat files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →